Opportunities to Improve Health Care Globally
In more than 50 markets around the world, Bristol-Myers Squibb researchers are working to create and sustain an outstanding pipeline in 10 areas of significant unmet medical need. Since 2002, we have delivered nine new medicines to the global market, all of which address debilitating and life-threatening diseases.
We are looking to build on these achievements by using our development expertise and innovative research capabilities to improve treatment options for patients in need.
Bristol-Myers Squibb disease areas of focus:
- Alzheimer's disease
- Psychiatric disorders
- Rheumatoid arthritis & related diseases
- Solid organ transplant rejection
Click here to learn more about Bristol-Myers Squibb's Research & Development organization or feel free to email us at email@example.com.